SNTI
Senti Biosciences·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural
Money flow analysis shows a robust 7.41/10 score with positive overall inflow, yet the trend is negative across block, small, medium, large, and extra-large flows. Analyst consensus is overwhelmingly bullish (Strong Buy 50%, Buy 50%) but historically unreliable (0% win rate). Combined, the signals suggest potential short-term volatility and risk.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-09
InstitutionChardan Capital
Times predicted4
Historical Win Rate0.0%
What is the analyst consensus for SNTI?
- SNTI holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.71/10 (Netural).
